Watch Ruth Faden, director of the Johns Hopkins Berman Institute of Bioethics, discuss the Institute of Medicine report she co-chaired on the need to study the safety of drugs after approval and throughout their time on the market.


BioCentury 06.10.12 - [3] Untying the Knot



Be the first to like.

Share

Leave a Reply